Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...

DexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

IRDM reports strong Q4 results, with a steady increase in service revenues and a growing subscriber base. It also issues a ...

Since it arrived back in 2010 the Duster has notched over two million sales and when it came to the UK a couple of years ...

UFP Industries has seen significant stock growth but recent performance has fallen a bit short of expectations. The company's ...

Feeling the pain of a 28% drop in the JD Sports share price over the past three months, our writer looks at the prospects for ...

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

Residents in several southern states were found to spend the highest percentage of their income on groceries, according to a new analysis by WalletHub.

U.S. retail sales dropped sharply last month, in part because cold weather kept more Americans indoors and dented sales at ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...